Phreesia (NYSE:PHR) Insider Sells $14,861.64 in Stock

Phreesia, Inc. (NYSE:PHR) insider Yvonne Hui sold 1,371 shares of the firm’s stock in a transaction on Monday, July 6th. The stock was sold at an average price of $10.84, for a total value of $14,861.64. Following the completion of the transaction, the insider owned 23,908 shares in the company, valued at $259,162.72. This represents a 5.42% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Yvonne Hui also recently made the following trade(s):

• On Friday, April 17th, Yvonne Hui sold 1,327 shares of Phreesia stock. The shares were sold at an average price of $9.28, for a total value of $12,314.56.
• On Thursday, April 16th, Yvonne Hui sold 10,063 shares of Phreesia stock. The shares were sold at an average price of $9.08, for a total value of $91,372.04.

Phreesia Trading Down 1.4%

PHR traded down $0.15 during midday trading on Tuesday, reaching $10.95. 765,895 shares of the company were exchanged, compared to its average volume of 1,742,383. The stock has a market capitalization of $676.51 million, a P/E ratio of 72.97 and a beta of 0.87. Phreesia, Inc. has a one year low of $7.77 and a one year high of $32.76. The stock’s 50-day simple moving average is $9.49 and its 200 day simple moving average is $11.74. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.76 and a current ratio of 1.76.

Phreesia (NYSE:PHR) last announced its quarterly earnings results on Wednesday, May 27th. The company reported $0.05 EPS for the quarter, beating analysts’ consensus estimates of $0.02 by $0.03. Phreesia had a return on equity of 5.13% and a net margin of 1.85%.The company had revenue of $130.94 million during the quarter, compared to analysts’ expectations of $130.08 million. During the same period in the prior year, the business posted ($0.07) EPS. Phreesia’s revenue was up 12.9% on a year-over-year basis. As a group, analysts forecast that Phreesia, Inc. will post 0.35 earnings per share for the current fiscal year.

Key Headlines Impacting Phreesia

Here are the key news stories impacting Phreesia this week:

• Negative Sentiment: Multiple law firms, including Rosen Law Firm, Holzer & Holzer, Howard G. Smith, and others, urged investors to join or lead securities class action claims against Phreesia ahead of a July 13 deadline. The allegations center on claims that the company downplayed slowing growth and overstated its business outlook. Article Title
• Negative Sentiment: Additional firms, including Bronstein, Gewirtz & Grossman, Portnoy Law Firm, Schall Law Firm, DJS Law Group, Bragar Eagel & Squire, Robbins LLP, and Faruqi & Faruqi, published similar alerts and investigations, reinforcing legal overhang and potential distraction/costs for Phreesia. Article Title

Analysts Set New Price Targets

Several equities analysts have recently issued reports on the stock. Truist Financial boosted their price target on shares of Phreesia from $11.00 to $12.00 and gave the company a “hold” rating in a report on Thursday, May 28th. Mizuho reduced their target price on Phreesia from $22.00 to $19.00 and set an “outperform” rating on the stock in a report on Tuesday, March 24th. KeyCorp decreased their target price on Phreesia from $15.00 to $12.00 and set an “overweight” rating for the company in a research note on Monday, April 13th. Piper Sandler downgraded Phreesia from an “overweight” rating to a “neutral” rating and set a $12.00 price target for the company. in a report on Thursday, May 28th. Finally, Canaccord Genuity Group dropped their price target on Phreesia from $22.00 to $16.00 and set a “buy” rating on the stock in a research report on Thursday, May 28th. Nine analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, Phreesia currently has a consensus rating of “Hold” and an average target price of $16.65.

Hedge Funds Weigh In On Phreesia

Large investors have recently bought and sold shares of the company. Greenhouse Funds LLLP increased its position in Phreesia by 16.8% during the third quarter. Greenhouse Funds LLLP now owns 3,882,527 shares of the company’s stock worth $91,317,000 after buying an additional 557,265 shares during the last quarter. SG Americas Securities LLC acquired a new stake in shares of Phreesia in the fourth quarter valued at approximately $1,203,000. Tudor Investment Corp ET AL bought a new position in shares of Phreesia during the 3rd quarter worth approximately $4,173,000. King Luther Capital Management Corp boosted its stake in shares of Phreesia by 172.6% during the 4th quarter. King Luther Capital Management Corp now owns 268,314 shares of the company’s stock worth $4,540,000 after acquiring an additional 169,900 shares during the period. Finally, Cambiar Investors LLC increased its holdings in shares of Phreesia by 48.9% during the 4th quarter. Cambiar Investors LLC now owns 358,474 shares of the company’s stock worth $6,065,000 after acquiring an additional 117,681 shares during the last quarter. Institutional investors and hedge funds own 92.10% of the company’s stock.

About Phreesia

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.